Fractionation schemes in adjuvant radiotherapy for breast cancer: review of the evidence and therapeutic approach at the National Institute of Cancerology, Colombia

被引:0
|
作者
Caicedo-Martinez, Maria [1 ]
del Castillo, Flavio Jose Rosero-Diaz [2 ]
Abi-Saab, Luis Guzman [3 ]
Briceno-Morales, Ximena [3 ]
Gamboa-Garay, oscar Andres [4 ]
Esguerra-Cantillo, Jose Alejandro [4 ]
Alvarez-Martinez, Alex [4 ]
Guerrero-Lizcano, Eduardo [4 ]
Ballesteros-Gomez, Holman [4 ]
Torres-Silva, Luis Angel [4 ]
Lehmann-Mosquera, Carlos [3 ]
Marino-Lozano, Ivan [3 ]
Garcia-Mora, Mauricio [3 ]
Aristizabal, Javier Angel [3 ]
Suarez-Rodriguez, Raul [3 ]
Duarte-Torres, Carlos Alfonso [3 ]
Diaz-Casas, Sandra Esperanza [3 ]
机构
[1] Univ Mil Nueva Granada, Inst Nacl Cancerol, Especializac Oncol Radioterap, Bogota, DC, Colombia
[2] Fdn Univ Ciencias Salud, Especializac Mastol, Inst Nacl Cancerol, Bogota, DC, Colombia
[3] Unidad Func Seno & Tejidos Blandos, Inst Nacl Cancerol, Bogota, DC, Colombia
[4] Inst Nacl Cancerol, Grp Area Oncol Radioterap, Bogota, DC, Colombia
来源
REVISTA COLOMBIANA DE CANCEROLOGIA | 2024年 / 28卷 / 01期
关键词
breast neoplasms; radiotherapy; treatment outcome; dose fractionation; radiation; radiation dose hypofractionation; female; postoperative care; UK STANDARDIZATION; FOLLOW-UP; CONSERVING SURGERY; IRRADIATION; WOMEN; TRIAL; HYPOFRACTIONATION; LUMPECTOMY; MASTECTOMY; OLDER;
D O I
10.35509/01239015.973
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiotherapy is a fundamental component in the management of breast cancer, particularly in the adjuvant setting, as its benefits in the treatment of breast cancer in terms of local recurrence, disease -free survival, and overall survival have been widely demonstrated. Hypofractionated radiation schedules are the current standard of adjuvant treatment in patients with early -stage breast cancer. Thus, the Radiation Oncology Unit and the Functional Unit for Breast and Soft Tissue Tumors of the Instituto Nacional de Cancerologia (INC) (Bogota, Colombia) decided to review the evidence on the subject and establish indications for different hypofractionation schemes at the INC, both for patients with cancers in early stages and for those with locally advanced tumors.
引用
收藏
页数:82
相关论文
共 50 条
  • [1] Clinical response in patients with breast tumours treated with postmastectomy conformal radiotherapy at the National Institute of Cancerology, Colombia
    Guerrero, Eduardo
    Ballesteros, Holman
    Felipe Torres, Luis
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2018, 22 (04): : 132 - 137
  • [2] Conservative surgery in breast cancer, experience from National Institute of Cancerology
    Martinez-Madrigal, M.
    Munoz-Gonzalez, D. E.
    GACETA MEXICANA DE ONCOLOGIA, 2009, 8 (04): : 142 - 145
  • [3] Intraoperative radiotherapy with electrons (IOERT) in patients with breast cancer: review of the evidence and therapeutic approach at the Instituto Nacional de Cancerología, Colombia
    Meneses-Riascos, Luis
    Jimenez-Ramirez, William
    Mendoza-Diaz, Sara
    Ballesteros-Gomez, Holman
    alvarez-Martinez, Alex
    Abi-Saab, Luis Guzman
    Briceno-Morales, Ximena
    Mosquera, Carlos Lehmann-
    Guerrero-Lizcano, Eduardo
    Torres-Silva, Luis Felipe
    Angel-Aristizabal, Javier
    Garcia-Mora, Mauricio
    Esguerra-Cantillo, Jose Alejandro
    Duarte-Torres, Carlos Alfonso
    Marino-Lozano, Ivan
    Suarez-Rodriguez, Raul
    Diaz-Casas, Sandra Esperanza
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2024, 28 (01):
  • [4] Locally advance breast cancer survival after radiotherapy following mastectomy at the National Cancer Institute of Colombia
    Ospino, Rosalba
    Cendales, Ricardo
    Cifuentes, Javier
    Sanchez, Zayda
    Galvis, Juan
    Bobadilla, Ivan
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2010, 14 (04): : 210 - 224
  • [5] Survival in Patients with Early Breast Cancer Treated with Conservative Surgery and Radiotherapy at the National Cancer Institute of Colombia
    Ospino, Rosalba
    Cendales, Ricardo
    Sanchez, Zayda
    Bobadilla, Ivan
    Galvis, Juan
    Cifuentes, Javier
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2011, 15 (02): : 75 - 84
  • [6] Adjuvant and neoadjuvant radiotherapy in breast cancer: A literaure review and update on the state of the evidence in 2020
    Belkacemi, Y.
    Debbi, K.
    Loganadane, G.
    Ghith, S.
    Hadhri, A.
    Hassani, W.
    Cherif, M. A.
    Coraggio, G.
    To, N. H.
    Colson-Durand, L.
    Grellier, N.
    CANCER RADIOTHERAPIE, 2020, 24 (6-7): : 482 - 492
  • [7] Update-Adjuvant radiotherapy of breast cancer: indications, target volume and fractionation
    Krug, David
    Maass, Nicolai
    Bauerschlag, Dirk
    Dunst, Juergen
    GYNAKOLOGE, 2022, 55 (05): : 315 - 323
  • [8] Adjuvant radiotherapy for malignant phyllodes tumours:National Cancer Institute, Malaysia experience
    Zaid, Rizma Mohd
    Mokhtar, Mohammad Nizam
    RADIOTHERAPY AND ONCOLOGY, 2024, 197 : S83 - S84
  • [9] Extension studies for the staging of infiltrating breast cancer. Review of evidence and therapeutic approach at the Instituto Nacional de Cancerologia - Colombia
    Pedroza-Duran, Ana
    Gonzalez-Hurtado, Daniel
    Quintero-Ortiz, Maria
    Guzman-AbiSaabd, Luis
    Briceno-Morales, Ximena
    Oswaldo Sanchez-Castillo, Jesus
    Bruges-Maya, Ricardo
    Contreras-Mejia, Fernando
    Lehmann-Mosquera, Carlos
    Garcia-Mora, Mauricio
    Angel-Aristizabal, Javier
    Marino-Lozano, Ivan
    Rojas, Eduardo
    Duarte-Torres, Carlos
    Diaz-Casas, Sandra E.
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 : 6 - 15
  • [10] Indications for neoadjuvant and adjuvant radiotherapy and chemotherapy in patients with retroperitoneal sarcoma: non-systematic review of the evidence and therapeutic approach at the Instituto Nacional de Cancerología, Colombia
    Rodriguez-Corredor, Javier
    Zuluaga-Liberato, Andrea Marcela
    Cuadrado-Franco, Daniela Maria
    Campillo-Pardo, Jorge
    Jurado-Sanabria, Natallie
    Alvarez-Martinez, Alex
    Sanchez-Castillo, Jesus Oswaldo
    Contreras-Mejia, Fernando
    Bruges-Maya, Ricardo
    Lehmann-Mosquera, Carlos
    Guerrero-Lizcano, Eduardo
    Ballesteros-Gomez, Holman
    Garcia-Mora, Mauricio
    Angel-Aristizabal, Javier
    Marino-Lozano, Ivan
    Suarez-Rodriguez, Raul
    Duarte-Torres, Carlos Alfonso
    Esguerra-Cantillo, Jose Alejandro
    Torres-Silva, Luis Felipe
    Ballen-Lozano, Diego Felipe
    Zapata-Laguado, Martin Ignacio
    Diaz-Casas, Sandra Esperanza
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2024, 28 (01):